Dr. Muhammad Kibriya | Cancer molecular genomics | Best Researcher Award
Dr. Muhammad Kibriya, University of Chicago, United States
Dr. Muhammad G. Kibriya is a Research Associate Professor at the Institute for Population and Precision Health, University of Chicago. He holds an MBBS from Dhaka University (1987) and a PhD in Medicine from the Medical Academy Sofia, Bulgaria (1994). With expertise in nephrology, diabetology, epidemiology, and cancer genomics, his research focuses on molecular genomics, gene-environment interactions, and oncogenesis. Dr. Kibriya has co-led large-scale studies like HEALS, BEST, and COMPASS. He pioneered a novel Luminex-based assay for telomere length measurement and has extensive experience in cutting-edge genomic technologies. 📊🧬
Publication Profile
Academic Background
Dr. Muhammad G. Kibriya earned his MBBS from the Institute for Postgraduate Medicine & Research, Dhaka University in 1987, followed by a PhD in Medicine from the Medical Academy Sofia, Bulgaria, in 1994. His multidisciplinary training spans medicine, nephrology, diabetology, epidemiology, environmental health, and cancer genomics, showcasing his comprehensive academic foundation for impactful research.
Research Interests
Dr. Kibriya’s research focuses on integrative molecular genomics and gene-environment interactions in cancer epidemiology. His work addresses critical areas such as oncogenesis and its applications in disease classification, therapeutic response, and prognosis across various cancers, including colorectal, breast, thyroid, and non-melanoma skin cancers. These interests align with global priorities in precision health and public health sciences.
Technical Expertise
Dr. Kibriya has extensive experience in advanced molecular genomics assays. These include genome-wide methylation, metagenomics, microbiome assays, high-throughput genome-wide genotyping, gene expression, and next-generation sequencing. His novel development of a non-PCR-based high-throughput assay for measuring relative telomere length demonstrates innovative thinking and technological advancement.
Research Focus
Dr. Muhammad G. Kibriya focuses on gene-environment interactions, particularly the molecular mechanisms underlying cancer and chronic diseases. His research spans non-melanoma skin cancer (NMSC), colorectal carcinoma, thyroid cancer, and the impacts of environmental exposures like arsenic and metal mixtures on epigenetics and transcriptomic profiles. He explores genetic mutations, DNA methylation, telomere dynamics, and inflammation-related pathways in cancer development and progression. Dr. Kibriya’s work integrates high-throughput sequencing, molecular profiling, and innovative assay development to address critical gaps in cancer therapy and environmental health. 🧬🌱🩺💡
Publication Top Notes
- Gene–Environment Interaction: Small Deletions (DELs) and Transcriptomic Profiles in NMSC
Cells, 2025 | DOI: 10.3390/cells14020095 - Exposure to Metal Mixtures and Telomere Length in Bangladeshi Children
American Journal of Epidemiology, 2025 | DOI: 10.1093/aje/kwae181 - Assessment of Multipollutant Exposures Using Silicone Wristbands Among Bangladeshi Youth
IJERPH, 2024 | DOI: 10.3390/ijerph21121691 - Association of KRAS Mutation and Gene Pathways in Colorectal Carcinoma
IJMS, 2024 | DOI: 10.3390/ijms25158094 - Molecular Profiling in NMSC in a Population Exposed to Arsenic
Cells, 2024 | DOI: 10.3390/cells13121056 - Association of Microsatellite Instability in Colorectal Carcinoma
Medicina, 2024 | DOI: 10.3390/medicina60030348 - Air Pollution Exposure and Cardiometabolic Biomarkers
Environmental Research, 2024 | DOI: 10.1016/j.envres.2023.117496 - Pathways Related to Colon Inflammation and Colorectal Carcinoma
Cancers, 2023 | DOI: 10.3390/cancers15112921 - DNA Promoter Methylation and BRAF Mutation in Thyroid Cancer
Current Oncology, 2023 | DOI: 10.3390/curroncol30030227 - DNA Methylation QTL Mapping Across Human Tissues
Nature Genetics, 2023 | DOI: 10.1038/s41588-022-01248-z - Fine-Mapping the 10q24.32 Arsenic Metabolism Efficiency Locus
PLOS Genetics, 2023 | DOI: 10.1371/journal.pgen.1010588 - Comparing Tissues of Early and Late Onset Colorectal Carcinoma
IJMS, 2022 | DOI: 10.3390/ijms232214261 - Arsenic Exposure and Transcriptomic Profile in Basal Cell Carcinoma
Cancers, 2022 | DOI: 10.3390/cancers14225598 - Spatial Accessibility of Primary Care and Hypertension Control
Circulation, 2022 | DOI: 10.1161/CIRCOUTCOMES.121.008845 - Relative Telomere Length in Colorectal Carcinoma
Cancers, 2022 | DOI: 10.3390/cancers14092250